It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2011.
2011 | Chennai, Tamil Nadu, India | ActiveShawin Pharmaceuticals Private Limited, a active private limited company, was established on 17 June 2011 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33110TN2011PTC081126. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a active non-compliant status. Its leadership includes Venkataramanan Santhanakrishnan (Director), Shanmugham Murali (Additional Director), Ambalavanan Rethinavel (Director). Past directors included Sarala Prabhakaran, Balaji Venkatesan, Abdul Majeeth. It holds ₹5.70 M open charges and no settled loans. Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at S-13, 15Th Avenue Jawaharlal Nehru Road, Ashok Nagar, Chennai, Tamil Nadu, 600083.
U33110TN2011PTC081126
081126
17 June 2011
₹5.00 M
₹5.00 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Shawin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkataramanan Santhanakrishnan | Director | 01 Oct 2012 | Current |
| Shanmugham Murali | Additional Director | 06 Jan 2014 | Current |
| Ambalavanan Rethinavel | Director | 17 Jun 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 12 Dec 2012 | Past |
| Pramod Abcsdd | Director | 31 Jan 2014 | Past |
| Pramod Abcsdd | Director | 08 Jul 2011 | Past |
| Pramod Abcsdd | Additional Director | 29 Feb 2012 | Past |
| Pramod Abcsdd | Director | 28 Sep 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Shawin Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Shawin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Nov 2011 | City Union Bank | ₹5.70 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Shawin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shawin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shawin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shawin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was recorded as a recent event.
The activity Shawin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Chennai. was completed.
The activity Shanmugham Murali was appointed as a Additional Director was appointed as a Additional Director on 06 Jan 2014 & has been associated with this company since 11 years 11 months . was completed.
Progress on Venkataramanan Santhanakrishnan was appointed as a Director was appointed as a Director on 01 Oct 2012 & has been associated with this company since 13 years 2 months . was documented.
A charge with City Union Bank of Rs. 5.70 M registered on 18 Nov 2011 with Charge ID 10328831 was modified on 31 Aug 2012. was recorded as a recent event.
A charge with City Union Bank amounted to Rs. 5.70 M with Charge ID 10328831 was registered on 18 Nov 2011. was recorded as a recent event.
The CIN of Shawin Pharmaceuticals Private Limited is U33110TN2011PTC081126.
Shawin Pharmaceuticals Private Limited is headquartered at S-13, 15Th Avenue Jawaharlal Nehru Road, Ashok Nagar, Chennai, Tamil Nadu, 600083.
Shawin Pharmaceuticals Private Limited was incorporated on 17 June 2011.
The current directors of Shawin Pharmaceuticals Private Limited are
The primary industry of Shawin Pharmaceuticals Private Limited is Pharma.
Shawin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Shawin Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Shawin Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX